Table 5.
Study or subgroup | Etoricoxib |
Diclofenac |
Weight | Peto OR, Fixed, 95% CI | ||
---|---|---|---|---|---|---|
Events | Total | Events | Total | |||
EDGE 2005 [Baraf et al. 2007] | 210 | 3593 | 95 | 3518 | 41.8% | 2.15 [1.71, 2.71] |
EDGE II [Krueger et al. 2008] | 240 | 2032 | 197 | 2054 | 55.9% | 1.26 [1.03, 1.54] |
ZACHER 2003 | 8 | 256 | 9 | 260 | 2.4% | 0.90 [0.34, 2.36] |
Total (95% CI) | 5881 | 5832 | 100.0% | 1.56 [1.35, 1.81] | ||
Total events | 458 | 301 |
Heterogeneity: chi squared = 13.17, degrees of freedom = 2 (p = 0.001); I2 = 85%. Test for overall effect: Z = 5.91 (p = 0.00001).
CI, confidence interval; OR, odds ratio.